Effects of chitosan particles in periodontal pathogens and gingival fibroblasts

Journal of Dental Research

Volumn 92, Issue 8, 2013, Pages 740-745

  Arancibia, R ^a   Maturana, C ^b   Silva, D ^a   Tobar, N ^b   Tapia, C ^b   Salazar, J C ^b   Martinez J ^b   Smith, P C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Aggregatibacter actinomycetemcomitans; biomaterials; inflammation; periodontal diseases; periodontitis; Porphyromonas gingivalis

Indexed keywords

3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; 3-(4,5-DIMETHYLTHIAZOL-2-YL)-5-(3-CARBOXYMETHOXYPHENYL)-2-(4-SULFOPHENYL)-2H-TETRAZOLIUM; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CHITOSAN; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; NANOPARTICLE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; TETRAZOLIUM; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR RELA;

ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BIOMATERIALS; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; GINGIVA; HUMAN; INFLAMMATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PERIODONTAL DISEASE; PERIODONTITIS; PHOSPHORYLATION; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; BIOMATERIALS; INFLAMMATION; PERIODONTAL DISEASES; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANTHRACENES; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIOLOGICAL TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; DINOPROSTONE; FIBROBLASTS; GINGIVA; HUMANS; INDICATORS AND REAGENTS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; L-LACTATE DEHYDROGENASE; MAP KINASE SIGNALING SYSTEM; NANOPARTICLES; NF-KAPPA B; PERIODONTAL DISEASES; PHOSPHORYLATION; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES; TRANSCRIPTION FACTOR RELA;

EID: 84880293427     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034513494816     Document Type: Article

References (31)

1. Arancibia R, Cáceres M, Martínez J, Smith PC. Triclosan inhibits tumor necrosis factor-alpha stimulated urokinase production in human gingival fibroblasts. J Periodontal Res. 2009 ; 44: 726-735
2. Båge T, Lindberg J, Lundeberg J, Modéer T, Yucel-Lindberg T. Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts. BMC Genomics. 2010 ; 11: 241
3. Båge T, Kats A, Lopez BS, Morgan G, Nilsson G, Burt I, et al. Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation. Am J Pathol. 2011 ; 178: 1676-1688
4. Choi BK, Kim KY, Yoo YJ, Oh SJ, Choi JH, Kim CY. In vitro antimicrobial activity of a chitooligosaccharide mixture against Actinobacillus actinomycetemcomitans and Streptococcus mutans. Int J Antimicrob Agents. 2001 ; 18: 553-557
5. Chou TC, Fu E, Shen EC. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem Biophys Res Commun. 2003 ; 308: 403-407
6. Costa EM, Silva S, Pina C, Tavaria FK, Pintado MM. Evaluation and insights into chitosan antimicrobial activity against anaerobic oral pathogens. Anaerobe. 2012 ; 18: 305-309
7. Davies C, Tournier C. Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies. Biochem Soc Trans. 2012 ; 40: 85-89
8. Domard A. A perspective on 30 years research on chitin and chitosan. Carbohydrate Polymers. 2011 ; 84: 696-703
9. Francesko A, Tzanov T. Chitin, chitosan and derivatives for wound healing and tissue engineering. Adv Biochem Eng Biotechnol. 2011 ; 125: 1-27
10. Ganno T, Yamada S, Ohara N, Matsunaga T, Yanagiguchi K, Ikeda T, et al. Early gene expression analyzed by cDNA microarray and real-time PCR in osteoblasts cultured with chitosan monomer. J Biomed Mater Res A. 2007 ; 82: 188-194
11. Huang YC, Vieira A, Huang KL, Yeh MK, Chiang CH. Pulmonary inflammation caused by chitosan microparticles. J Biomed Mater Res A. 2005 ; 75: 283-287
12. Ikinci G, Senel S, Akincibay H, Kas S, Ercis S, Wilson CG, et al. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm. 2002 ; 235: 121-127
13. Kim MS, Sung MJ, Seo SB, Yoo SJ, Lim WK, Kim HM. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid β peptide and interleukin-1β. Neurosci Lett. 2002 ; 321: 105-109
14. Mohammadpourdounighi N, Behfar A, Ezabadi A, Zolfagharian H, Heydari M. Preparation of chitosan nanoparticles containing Naja naja oxiana snake venom. Nanomedicine. 2010 ; 6: 137-143
15. Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ, et al. Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci USA. 2011 ; 108: 17117-17122
16. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol. 2007 2000 ; 43: 85-101
17. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol. 1993 ; 64: 432-444
18. Pangestuti R, Bak SS, Kim SK. Attenuation of pro-inflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway. Int J Biol Macromol. 2011 ; 49: 599-606
19. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol. 2000 2000 ; 24: 239-252
20. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005 ; 366: 1809-1820
21. Preshaw PM, Heasman PA. Prostaglandin E2 concentrations in gingival crevicular fluid: observations in untreated chronic periodontitis. J Clin Periodontol. 2002 ; 29: 15-20
22. Salvi GE, Lang NP. The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des. 2005 ; 11: 1757-1769
23. Sarasam AR, Brown P, Khajotia SS, Dmytryk JJ, Madihally SV. Antibacterial activity of chitosan-based matrices on oral pathogens. J Mater Sci Mater Med. 2008 ; 19: 1083-1090
24. Shimojoh M, Kojima T, Nakajima K, Hatta K, Katoh A, Kurita K. Branched chitins as nonnatural immunomodulatory biopolymers: secretions of TNF-r and NO by direct stimulation of macrophages. Biomacromolecules. 2010 ; 11: 1212-1216
25. Silva D, Arancibia R, Tapia C, Acuña C, Diaz-Dosque M, Cáceres M, et al. Chitosan and platelet-derived growth factor synergistically stimulate cell proliferation in gingival fibroblasts. J Periodontal Res. 2013 ;:
26. Wei P, Ma P, Xu QS, Bai QH, Gu JG, Xi H, et al. Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro. Glycoconj J. 2012 ; 29: 285-295
27. Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol. 1989 ; 60: 485-490
28. Wu GJ, Tsai GJ. Chitooligosaccharides in combination with interferon-gamma increase nitric oxide production via nuclear factor-kappaB activation in murine RAW264.7 macrophages. Food Chem Toxicol. 2007 ; 45: 250-258
29. Yoon HJ, Moon ME, Park HS, Im SY, Kim YH. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem Biophys Res Commun. 2007 ; 358: 954-959
30. Yu Z, Zhao L, Ke H. Potential role of nuclear factor-kappaB in the induction of nitric oxide and tumor necrosis factor-alpha by oligochitosan in macrophages. Int Immunopharmacol. 2004 ; 4: 193-200
31. Yucel-Lindberg T, Nilsson S, Modéer T. Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-1beta and tumor necrosis factor alpha in human gingival fibroblasts. J Dent Res. 1999 ; 78: 61-68